PEDIATRICS Vol. 98 No. 5 November 1996, pp. 911-917
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Botto, L. D.
Right arrow Articles by Erickson, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Botto, L. D.
Right arrow Articles by Erickson, J. D.

Periconceptional Multivitamin Use and the Occurrence of Conotruncal Heart Defects: Results From a Population-based, Case-Control Study

Lorenzo D. Botto MD1, Muin J. Khoury MD, PhD2, Joseph Mulinare MD, MSPH2, and J. David Erickson DDS, PhD2

1 Epidemic Intelligence Service, Epidemiology Program Office; Birth Defects and Genetic Diseases Branch, Division of Birth Defects and Developmental Disabilities, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia
2 Birth Defects and Genetic Diseases Branch, Division of Birth Defects and Developmental Disabilities, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia

Objective. The preventive efficacy of the periconceptional use of multivitamins is well established for neural tube defects, much less so for other birth defects. We conducted a population-based, case-control study to assess the effects of multivitamin use on the risk for conotruncal defects, a group of severe heart defects that includes transposition of the great arteries, tetralogy of Fallot, and truncus arteriosus.

Methods. From the population-based Atlanta Birth Defects Case-Control Study, we identified 158 case infants with conotruncal defects and 3026 unaffected, randomly chosen control infants, born from 1968 through 1980 to mothers residing in metropolitan Atlanta. Periconceptional multivitamin use was defined as reported regular use from 3 months before conception through the third month of pregnancy. We present the results of the crude analysis, because the multivariate model yielded essentially identical results.

Results. Mothers who reported periconceptional multivitamin use had a 43% lower risk of having infants with conotruncal defects (odds ratio [OR], 0.57; 95% confidence interval [CI], 0.33 to 1.00) than did mothers who reported no use. The estimated relative risk was lowest for isolated conotruncal defects (OR, 0.41; 95% CI, 0.20 to 0.84) compared with those associated with noncardiac defects (OR, 0.91; 95% CI, 0.33 to 2.52) or a recognized syndrome (OR, 1.82; 95% CI, 0.31 to 10.67). Among anatomic subgroups of defects, transposition of the great arteries showed the greatest reduction in risk (OR, 0.36; 95% CI, 0.15 to 089).

Conclusions. Periconceptional multivitamin use is associated with a reduced risk for conotruncal defects. These findings could have major implications for the prevention of these birth defects.

Submitted on September 29, 1995
Accepted on January 2, 1996




This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
J. Yang, S. L. Carmichael, M. Canfield, J. Song, G. M. Shaw, and the National Birth Defects Prevention Study
Socioeconomic Status in Relation to Selected Birth Defects in a Large Multicentered US Case-Control Study
Am. J. Epidemiol., January 15, 2008; 167(2): 145 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
C. Hoekstra, Z. Z. Zhao, C. B. Lambalk, G. Willemsen, N. G. Martin, D. I. Boomsma, and G. W. Montgomery
Dizygotic twinning
Hum. Reprod. Update, January 1, 2008; 14(1): 37 - 47.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
I.M. van Beynum, M. den Heijer, H.J. Blom, and L. Kapusta
The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis
QJM, December 1, 2007; 100(12): 743 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. C Antony
In utero physiology: role of folic acid in nutrient delivery and fetal development
Am. J. Clinical Nutrition, February 1, 2007; 85(2): 598S - 603S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
T. Tamura and M. F. Picciano
Folate and human reproduction
Am. J. Clinical Nutrition, May 1, 2006; 83(5): 993 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
W. L. Zhu, Y. Li, L. Yan, J. Dao, and S. Li
Maternal and offspring MTHFR gene C677T polymorphism as predictors of congenital atrial septal defect and patent ductus arteriosus
Mol. Hum. Reprod., January 1, 2006; 12(1): 51 - 54.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. A Hobbs, M. A Cleves, W. Zhao, S. Melnyk, and S J. James
Congenital heart defects and maternal biomarkers of oxidative stress
Am. J. Clinical Nutrition, September 1, 2005; 82(3): 598 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. M. Gilboa, P. Mendola, A. F. Olshan, P. H. Langlois, D. A. Savitz, D. Loomis, A. H. Herring, and D. E. Fixler
Relation between Ambient Air Quality and Selected Birth Defects, Seven County Study, Texas, 1997-2000
Am. J. Epidemiol., August 1, 2005; 162(3): 238 - 252.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
D. Li, L. Pickell, Y. Liu, Q. Wu, J. S Cohn, and R. Rozen
Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 188 - 195.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. J. Boot, R. P.M. Steegers-Theunissen, R. E. Poelmann, L. van Iperen, and A. C. Gittenberger-de Groot
Cardiac outflow tract malformations in chick embryos exposed to homocysteine
Cardiovasc Res, November 1, 2004; 64(2): 365 - 373.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. Hernandez-Diaz, M. A. Hernan, K. Meyer, M. M. Werler, and A. A. Mitchell
Case-Crossover and Case-Time-Control Designs in Birth Defects Epidemiology
Am. J. Epidemiol., August 15, 2003; 158(4): 385 - 391.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. Correa, L. Botto, Y. Liu, J. Mulinare, and J. D. Erickson
Do Multivitamin Supplements Attenuate the Risk for Diabetes-Associated Birth Defects?
Pediatrics, May 1, 2003; 111(5): 1146 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
Grown-up congenital heart (GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK
Heart, September 1, 2002; 88(90001): i1 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. F. Myers, S. Li, A. Correa-Villasenor, Z. Li, C. A. Moore, S. X. Hong, R. J. Berry, and the China-US Collaborative Project for Neural Tube
Folic Acid Supplementation and Risk for Imperforate Anus in China
Am. J. Epidemiol., December 1, 2001; 154(11): 1051 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Junker, S. Kotthoff, H. Vielhaber, S. Halimeh, A. Kosch, H.-G. Koch, R. Kassenbohmer, B. Heineking, and U. Nowak-Gottl
Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease
Cardiovasc Res, August 1, 2001; 51(2): 251 - 254.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. L. Coté
Noninvasive and Minimally-Invasive Optical Monitoring Technologies
J. Nutr., May 1, 2001; 131(5): 1596S - 1604.
[Abstract] [Full Text]

Home page
 NEJMHome page
S. Hernandez-Diaz, M. M. Werler, A. M. Walker, and A. A. Mitchell
Folic Acid Antagonists during Pregnancy and the Risk of Birth Defects
N. Engl. J. Med., November 30, 2000; 343(22): 1608 - 1614.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
V. Azais-Braesco and G. Pascal
Vitamin A in pregnancy: requirements and safety limits
Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1325S - 1333.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
Folic acid: the opportunity that still exists
Can. Med. Assoc. J., May 1, 2000; 162(11): 1571 - 1572.


Home page
 Am. J. Clin. Nutr.Home page
S. E. Vollset, H. Refsum, L. M Irgens, B. M. Emblem, A. Tverdal, H. K Gjessing, A. L. B. Monsen, and P. M. Ueland
Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study
Am. J. Clinical Nutrition, April 1, 2000; 71(4): 962 - 968.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
T. H. ROSENQUIST, A. M. SCHNEIDER, and D. T. MONAGHAN
N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities
FASEB J, September 1, 1999; 13(12): 1523 - 1531.
[Abstract] [Full Text]

Home page
 JAMAHome page
Use of Folic Acid-Containing Supplements Among Women of Childbearing Age--United States, 1997
JAMA, May 13, 1998; 279(18): 1430 - 1430.
[Full Text] [PDF]

Home page
 JWatch GeneralHome page
PERICONCEPTIONAL MULTIVITAMINS MAY PREVENT HEART DEFECTS
Journal Watch (General), November 22, 1996; 1996(1122): 3 - 3.
[Full Text]